We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
Help your team understand why they need to meet the website and mobile app accessibility regulations.
The current conditions affecting boaters on the River Thames and what the warnings mean.
Travel and clinical advice on yellow fever including symptoms, diagnosis and epidemiology.
The eighth annual #MedSafetyWeek social media campaign will take place from 6 to 12 November 2023. It will focus on the importance of reporting suspected adverse reactions to medicines and suspected problems with medical devices. We ask healthcare professionals to...
Find out what you should consider before using an umbrella company to make sure it complies with the tax rules.
Whether you’re a patient, healthcare professional or carer, this year’s #MedSafetyWeek campaign is calling on you to help improve the safety of medical products by reporting any suspected side effects and adverse incidents to the MHRA Yellow Card scheme.
Guidance for specialists for initiation of valproate in female patients and for annual review and pregnancy testing to support adherence to pregnancy prevention requirements during the pandemic.
Information for exams officers about using the Parcelforce Worldwide yellow label service to dispatch exam scripts for general qualifications.
The review of the safety of isotretinoin has concluded.
Report a problem ('adverse incident') with a medical device or medicine to MHRA using the Yellow Card Scheme
Rights of way and right to roam - access rights of way, open access and permissive access land, use common lands, the Countryside Code, report problems.
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Information and guidance on a range of medical devices for users and patients.
Food and drink labelling and packaging regulations - what you must show, warnings, health and organic labels and packaging standards.
Learn how to check if your website or mobile app is accessible.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.